InChIKey	UTNUDOFZCWSZMS-YFHOEESVSA-N
Compound Name	Teriflunomide
Canonical SMILES	C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Cross-Family
Avg pChEMBL	6.46
Source	ChEMBL;BindingDB

DrugBank ID	DB08880
Drug Name	Teriflunomide
CAS Number	163451-81-8
Groups	approved investigational
ATC Codes	L04AK02
Description	Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated for the treatment of multiple sclerosis, specifically relapsing forms. The FDA label states an important warning...

---

Categories: Acids, Acyclic Amines Analgesics Analgesics, Non-Narcotic Aniline Compounds Anti-Inflammatory Agents Antineoplastic and Immunomodulating Agents Antirheumatic Agents BCRP/ABCG2 Inhibitors BCRP/ABCG2 Substrates Benzene Derivatives Butyrates Cytochrome P-450 CYP1A2 Inducers Cytochrome P-450 CYP1A2 Inducers (strength unknown) Cytochrome P-450 CYP1A2 Inducers (weak) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (moderate) Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Dihydroorotate Dehydrogenase Inhibitors Dihydroorotate dehydrogenase (DHODH) inhibitors Fatty Acids Fatty Acids, Volatile Hepatotoxic Agents Hydroxy Acids Immunologic Factors Immunomodulatory Agents Immunosuppressive Agents Lipids OAT3/SLC22A8 Inhibitors OATP1B1/SLCO1B1 Inhibitors Peripheral Nervous System Agents Pyrimidine Synthesis Inhibitor Selective Immunosuppressants Sensory System Agents

---

Cross-references: BindingDB: 50018011 ChEBI: 68540 CHEMBL973 ChemSpider: 16737143 Drugs Product Database (DPD): 22169 D10172 PDB: A26 PubChem:54684141 PubChem:347827807 RxCUI: 1310520 Wikipedia: Teriflunomide ZINC: ZINC000013512456